nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A5—Beclomethasone—psoriasis	0.074	0.108	CbGbCtD
Nisoldipine—CYP1A2—Clobetasol propionate—psoriasis	0.0726	0.106	CbGbCtD
Nisoldipine—CYP1A2—Methoxsalen—psoriasis	0.0382	0.0557	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0315	0.046	CbGbCtD
Nisoldipine—CYP3A7—Hydrocortisone—psoriasis	0.0315	0.046	CbGbCtD
Nisoldipine—CYP3A7—Cyclosporine—psoriasis	0.0297	0.0434	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0297	0.0434	CbGbCtD
Nisoldipine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0294	0.043	CbGbCtD
Nisoldipine—CACNA1S—pes—psoriasis	0.0286	0.858	CbGeAlD
Nisoldipine—CYP3A4—Calcitriol—psoriasis	0.0257	0.0375	CbGbCtD
Nisoldipine—CYP3A5—Hydrocortisone—psoriasis	0.0236	0.0345	CbGbCtD
Nisoldipine—CYP3A5—Cyclosporine—psoriasis	0.0223	0.0326	CbGbCtD
Nisoldipine—CYP3A4—Methoxsalen—psoriasis	0.02	0.0292	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0196	0.0286	CbGbCtD
Nisoldipine—CYP3A7—Dexamethasone—psoriasis	0.0196	0.0286	CbGbCtD
Nisoldipine—ABCB1—Mycophenolate mofetil—psoriasis	0.0192	0.028	CbGbCtD
Nisoldipine—ABCB1—Betamethasone—psoriasis	0.0164	0.024	CbGbCtD
Nisoldipine—ABCB1—Prednisolone—psoriasis	0.0162	0.0237	CbGbCtD
Nisoldipine—ABCB1—Hydrocortisone—psoriasis	0.0154	0.0224	CbGbCtD
Nisoldipine—ABCB1—Prednisone—psoriasis	0.0153	0.0224	CbGbCtD
Nisoldipine—CYP3A5—Dexamethasone—psoriasis	0.0147	0.0214	CbGbCtD
Nisoldipine—ABCB1—Cyclosporine—psoriasis	0.0145	0.0212	CbGbCtD
Nisoldipine—CYP3A4—Cholecalciferol—psoriasis	0.0132	0.0193	CbGbCtD
Nisoldipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0115	0.0168	CbGbCtD
Nisoldipine—CYP3A4—Triamcinolone—psoriasis	0.0115	0.0168	CbGbCtD
Nisoldipine—CYP3A4—Betamethasone—psoriasis	0.00985	0.0144	CbGbCtD
Nisoldipine—CYP3A4—Prednisolone—psoriasis	0.00972	0.0142	CbGbCtD
Nisoldipine—ABCB1—Dexamethasone—psoriasis	0.00956	0.014	CbGbCtD
Nisoldipine—CYP3A4—Hydrocortisone—psoriasis	0.00921	0.0134	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—psoriasis	0.00918	0.0134	CbGbCtD
Nisoldipine—CYP3A4—Cyclosporine—psoriasis	0.0087	0.0127	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—psoriasis	0.00768	0.0112	CbGbCtD
Nisoldipine—CYP3A4—Dexamethasone—psoriasis	0.00573	0.00836	CbGbCtD
Nisoldipine—CACNA1S—tendon—psoriasis	0.00219	0.0657	CbGeAlD
Nisoldipine—CACNB2—tendon—psoriasis	0.00132	0.0395	CbGeAlD
Nisoldipine—CACNA2D1—tendon—psoriasis	0.00124	0.0371	CbGeAlD
Nisoldipine—Myalgia—Hydrocortisone—psoriasis	0.000143	0.000509	CcSEcCtD
Nisoldipine—Malaise—Triamcinolone—psoriasis	0.000142	0.000507	CcSEcCtD
Nisoldipine—Headache—Hydroxyurea—psoriasis	0.000142	0.000507	CcSEcCtD
Nisoldipine—Anxiety—Hydrocortisone—psoriasis	0.000142	0.000507	CcSEcCtD
Nisoldipine—Vertigo—Triamcinolone—psoriasis	0.000142	0.000505	CcSEcCtD
Nisoldipine—Syncope—Triamcinolone—psoriasis	0.000141	0.000504	CcSEcCtD
Nisoldipine—Discomfort—Hydrocortisone—psoriasis	0.000141	0.000502	CcSEcCtD
Nisoldipine—Hypotension—Mycophenolate mofetil—psoriasis	0.00014	0.0005	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00014	0.0005	CcSEcCtD
Nisoldipine—Oedema—Prednisolone—psoriasis	0.00014	0.000499	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—psoriasis	0.00014	0.000498	CcSEcCtD
Nisoldipine—Insomnia—Cyclosporine—psoriasis	0.000139	0.000496	CcSEcCtD
Nisoldipine—Loss of consciousness—Triamcinolone—psoriasis	0.000139	0.000494	CcSEcCtD
Nisoldipine—Paraesthesia—Cyclosporine—psoriasis	0.000138	0.000493	CcSEcCtD
Nisoldipine—Shock—Prednisolone—psoriasis	0.000138	0.000491	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—psoriasis	0.000138	0.000491	CcSEcCtD
Nisoldipine—Cough—Triamcinolone—psoriasis	0.000138	0.000491	CcSEcCtD
Nisoldipine—Dyspnoea—Cyclosporine—psoriasis	0.000137	0.000489	CcSEcCtD
Nisoldipine—Somnolence—Cyclosporine—psoriasis	0.000137	0.000488	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000137	0.000488	CcSEcCtD
Nisoldipine—Oedema—Hydrocortisone—psoriasis	0.000137	0.000487	CcSEcCtD
Nisoldipine—Tachycardia—Prednisolone—psoriasis	0.000137	0.000487	CcSEcCtD
Nisoldipine—Insomnia—Mycophenolate mofetil—psoriasis	0.000136	0.000484	CcSEcCtD
Nisoldipine—Dyspepsia—Cyclosporine—psoriasis	0.000135	0.000483	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisolone—psoriasis	0.000135	0.000483	CcSEcCtD
Nisoldipine—Nausea—Hydroxyurea—psoriasis	0.000135	0.000481	CcSEcCtD
Nisoldipine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000135	0.00048	CcSEcCtD
Nisoldipine—Pruritus—Mycophenolic acid—psoriasis	0.000134	0.00048	CcSEcCtD
Nisoldipine—Shock—Hydrocortisone—psoriasis	0.000134	0.00048	CcSEcCtD
Nisoldipine—Myalgia—Triamcinolone—psoriasis	0.000134	0.000479	CcSEcCtD
Nisoldipine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000134	0.000477	CcSEcCtD
Nisoldipine—Decreased appetite—Cyclosporine—psoriasis	0.000134	0.000477	CcSEcCtD
Nisoldipine—Tachycardia—Hydrocortisone—psoriasis	0.000133	0.000476	CcSEcCtD
Nisoldipine—Somnolence—Mycophenolate mofetil—psoriasis	0.000133	0.000476	CcSEcCtD
Nisoldipine—Ill-defined disorder—Betamethasone—psoriasis	0.000133	0.000474	CcSEcCtD
Nisoldipine—Ill-defined disorder—Dexamethasone—psoriasis	0.000133	0.000474	CcSEcCtD
Nisoldipine—Discomfort—Triamcinolone—psoriasis	0.000133	0.000473	CcSEcCtD
Nisoldipine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000132	0.000471	CcSEcCtD
Nisoldipine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000132	0.000471	CcSEcCtD
Nisoldipine—Dry mouth—Triamcinolone—psoriasis	0.000131	0.000468	CcSEcCtD
Nisoldipine—Angioedema—Dexamethasone—psoriasis	0.000131	0.000466	CcSEcCtD
Nisoldipine—Angioedema—Betamethasone—psoriasis	0.000131	0.000466	CcSEcCtD
Nisoldipine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00013	0.000465	CcSEcCtD
Nisoldipine—Anorexia—Hydrocortisone—psoriasis	0.00013	0.000465	CcSEcCtD
Nisoldipine—Diarrhoea—Mycophenolic acid—psoriasis	0.00013	0.000464	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—psoriasis	0.00013	0.000463	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—psoriasis	0.00013	0.000462	CcSEcCtD
Nisoldipine—Malaise—Betamethasone—psoriasis	0.000129	0.00046	CcSEcCtD
Nisoldipine—Malaise—Dexamethasone—psoriasis	0.000129	0.00046	CcSEcCtD
Nisoldipine—Oedema—Triamcinolone—psoriasis	0.000129	0.000459	CcSEcCtD
Nisoldipine—Vertigo—Betamethasone—psoriasis	0.000129	0.000459	CcSEcCtD
Nisoldipine—Vertigo—Dexamethasone—psoriasis	0.000129	0.000459	CcSEcCtD
Nisoldipine—Syncope—Betamethasone—psoriasis	0.000128	0.000458	CcSEcCtD
Nisoldipine—Syncope—Dexamethasone—psoriasis	0.000128	0.000458	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—psoriasis	0.000128	0.000456	CcSEcCtD
Nisoldipine—Hypotension—Hydrocortisone—psoriasis	0.000128	0.000456	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—psoriasis	0.000127	0.000453	CcSEcCtD
Nisoldipine—Feeling abnormal—Cyclosporine—psoriasis	0.000127	0.000452	CcSEcCtD
Nisoldipine—Shock—Triamcinolone—psoriasis	0.000127	0.000452	CcSEcCtD
Nisoldipine—Insomnia—Prednisolone—psoriasis	0.000127	0.000451	CcSEcCtD
Nisoldipine—Alopecia—Prednisone—psoriasis	0.000126	0.000451	CcSEcCtD
Nisoldipine—Loss of consciousness—Dexamethasone—psoriasis	0.000126	0.000449	CcSEcCtD
Nisoldipine—Loss of consciousness—Betamethasone—psoriasis	0.000126	0.000449	CcSEcCtD
Nisoldipine—Dizziness—Mycophenolic acid—psoriasis	0.000126	0.000448	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—psoriasis	0.000126	0.000448	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisolone—psoriasis	0.000126	0.000448	CcSEcCtD
Nisoldipine—Tachycardia—Triamcinolone—psoriasis	0.000126	0.000448	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000125	0.000444	CcSEcCtD
Nisoldipine—Hyperhidrosis—Triamcinolone—psoriasis	0.000124	0.000444	CcSEcCtD
Nisoldipine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000124	0.000441	CcSEcCtD
Nisoldipine—Insomnia—Hydrocortisone—psoriasis	0.000124	0.000441	CcSEcCtD
Nisoldipine—Paraesthesia—Hydrocortisone—psoriasis	0.000123	0.000438	CcSEcCtD
Nisoldipine—Urticaria—Cyclosporine—psoriasis	0.000122	0.000436	CcSEcCtD
Nisoldipine—Myalgia—Dexamethasone—psoriasis	0.000122	0.000434	CcSEcCtD
Nisoldipine—Myalgia—Betamethasone—psoriasis	0.000122	0.000434	CcSEcCtD
Nisoldipine—Body temperature increased—Cyclosporine—psoriasis	0.000122	0.000434	CcSEcCtD
Nisoldipine—Anxiety—Betamethasone—psoriasis	0.000121	0.000433	CcSEcCtD
Nisoldipine—Anxiety—Dexamethasone—psoriasis	0.000121	0.000433	CcSEcCtD
Nisoldipine—Discomfort—Dexamethasone—psoriasis	0.00012	0.000429	CcSEcCtD
Nisoldipine—Discomfort—Betamethasone—psoriasis	0.00012	0.000429	CcSEcCtD
Nisoldipine—Dyspepsia—Hydrocortisone—psoriasis	0.00012	0.000429	CcSEcCtD
Nisoldipine—Rash—Mycophenolic acid—psoriasis	0.00012	0.000428	CcSEcCtD
Nisoldipine—Dermatitis—Mycophenolic acid—psoriasis	0.00012	0.000427	CcSEcCtD
Nisoldipine—Urticaria—Mycophenolate mofetil—psoriasis	0.000119	0.000425	CcSEcCtD
Nisoldipine—Headache—Mycophenolic acid—psoriasis	0.000119	0.000425	CcSEcCtD
Nisoldipine—Decreased appetite—Hydrocortisone—psoriasis	0.000119	0.000424	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—psoriasis	0.000119	0.000423	CcSEcCtD
Nisoldipine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000119	0.000423	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000117	0.000418	CcSEcCtD
Nisoldipine—Oedema—Betamethasone—psoriasis	0.000117	0.000417	CcSEcCtD
Nisoldipine—Oedema—Dexamethasone—psoriasis	0.000117	0.000417	CcSEcCtD
Nisoldipine—Insomnia—Triamcinolone—psoriasis	0.000116	0.000415	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisone—psoriasis	0.000116	0.000412	CcSEcCtD
Nisoldipine—Paraesthesia—Triamcinolone—psoriasis	0.000116	0.000412	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisolone—psoriasis	0.000115	0.000411	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—psoriasis	0.000115	0.000411	CcSEcCtD
Nisoldipine—Anaemia—Prednisone—psoriasis	0.000115	0.000411	CcSEcCtD
Nisoldipine—Shock—Betamethasone—psoriasis	0.000115	0.00041	CcSEcCtD
Nisoldipine—Shock—Dexamethasone—psoriasis	0.000115	0.00041	CcSEcCtD
Nisoldipine—Dyspnoea—Triamcinolone—psoriasis	0.000115	0.000409	CcSEcCtD
Nisoldipine—Tachycardia—Dexamethasone—psoriasis	0.000114	0.000406	CcSEcCtD
Nisoldipine—Tachycardia—Betamethasone—psoriasis	0.000114	0.000406	CcSEcCtD
Nisoldipine—Angioedema—Prednisone—psoriasis	0.000114	0.000406	CcSEcCtD
Nisoldipine—Hypersensitivity—Cyclosporine—psoriasis	0.000113	0.000404	CcSEcCtD
Nisoldipine—Dyspepsia—Triamcinolone—psoriasis	0.000113	0.000404	CcSEcCtD
Nisoldipine—Nausea—Mycophenolic acid—psoriasis	0.000113	0.000403	CcSEcCtD
Nisoldipine—Hyperhidrosis—Dexamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Nisoldipine—Hyperhidrosis—Betamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Nisoldipine—Feeling abnormal—Hydrocortisone—psoriasis	0.000113	0.000402	CcSEcCtD
Nisoldipine—Malaise—Prednisone—psoriasis	0.000112	0.000401	CcSEcCtD
Nisoldipine—Vertigo—Prednisone—psoriasis	0.000112	0.000399	CcSEcCtD
Nisoldipine—Syncope—Prednisone—psoriasis	0.000112	0.000399	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—psoriasis	0.000112	0.000398	CcSEcCtD
Nisoldipine—Anorexia—Dexamethasone—psoriasis	0.000111	0.000397	CcSEcCtD
Nisoldipine—Anorexia—Betamethasone—psoriasis	0.000111	0.000397	CcSEcCtD
Nisoldipine—Urticaria—Prednisolone—psoriasis	0.000111	0.000397	CcSEcCtD
Nisoldipine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000111	0.000394	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisone—psoriasis	0.00011	0.000391	CcSEcCtD
Nisoldipine—Hypotension—Dexamethasone—psoriasis	0.000109	0.000389	CcSEcCtD
Nisoldipine—Hypotension—Betamethasone—psoriasis	0.000109	0.000389	CcSEcCtD
Nisoldipine—Pruritus—Cyclosporine—psoriasis	0.000109	0.000388	CcSEcCtD
Nisoldipine—Urticaria—Hydrocortisone—psoriasis	0.000109	0.000387	CcSEcCtD
Nisoldipine—Body temperature increased—Hydrocortisone—psoriasis	0.000108	0.000385	CcSEcCtD
Nisoldipine—Chills—Methotrexate—psoriasis	0.000107	0.000383	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000106	0.000379	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000106	0.000379	CcSEcCtD
Nisoldipine—Pruritus—Mycophenolate mofetil—psoriasis	0.000106	0.000379	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—psoriasis	0.000106	0.000378	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—psoriasis	0.000106	0.000378	CcSEcCtD
Nisoldipine—Feeling abnormal—Triamcinolone—psoriasis	0.000106	0.000378	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—psoriasis	0.000106	0.000377	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—psoriasis	0.000106	0.000377	CcSEcCtD
Nisoldipine—Insomnia—Betamethasone—psoriasis	0.000106	0.000377	CcSEcCtD
Nisoldipine—Insomnia—Dexamethasone—psoriasis	0.000106	0.000377	CcSEcCtD
Nisoldipine—Diarrhoea—Cyclosporine—psoriasis	0.000105	0.000375	CcSEcCtD
Nisoldipine—Paraesthesia—Dexamethasone—psoriasis	0.000105	0.000374	CcSEcCtD
Nisoldipine—Paraesthesia—Betamethasone—psoriasis	0.000105	0.000374	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—psoriasis	0.000105	0.000374	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisolone—psoriasis	0.000103	0.000368	CcSEcCtD
Nisoldipine—Dyspepsia—Dexamethasone—psoriasis	0.000103	0.000367	CcSEcCtD
Nisoldipine—Dyspepsia—Betamethasone—psoriasis	0.000103	0.000367	CcSEcCtD
Nisoldipine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000103	0.000366	CcSEcCtD
Nisoldipine—Urticaria—Triamcinolone—psoriasis	0.000102	0.000365	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—psoriasis	0.000102	0.000364	CcSEcCtD
Nisoldipine—Body temperature increased—Triamcinolone—psoriasis	0.000102	0.000363	CcSEcCtD
Nisoldipine—Dizziness—Cyclosporine—psoriasis	0.000102	0.000363	CcSEcCtD
Nisoldipine—Oedema—Prednisone—psoriasis	0.000102	0.000363	CcSEcCtD
Nisoldipine—Decreased appetite—Dexamethasone—psoriasis	0.000102	0.000362	CcSEcCtD
Nisoldipine—Decreased appetite—Betamethasone—psoriasis	0.000102	0.000362	CcSEcCtD
Nisoldipine—Hypersensitivity—Hydrocortisone—psoriasis	0.000101	0.000359	CcSEcCtD
Nisoldipine—Shock—Prednisone—psoriasis	0.0001	0.000357	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—psoriasis	9.92e-05	0.000354	CcSEcCtD
Nisoldipine—Dizziness—Mycophenolate mofetil—psoriasis	9.92e-05	0.000354	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisone—psoriasis	9.83e-05	0.000351	CcSEcCtD
Nisoldipine—Rash—Cyclosporine—psoriasis	9.7e-05	0.000346	CcSEcCtD
Nisoldipine—Anorexia—Prednisone—psoriasis	9.69e-05	0.000346	CcSEcCtD
Nisoldipine—Dermatitis—Cyclosporine—psoriasis	9.69e-05	0.000346	CcSEcCtD
Nisoldipine—Pruritus—Hydrocortisone—psoriasis	9.67e-05	0.000345	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—psoriasis	9.66e-05	0.000345	CcSEcCtD
Nisoldipine—Headache—Cyclosporine—psoriasis	9.63e-05	0.000344	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—psoriasis	9.62e-05	0.000343	CcSEcCtD
Nisoldipine—Feeling abnormal—Betamethasone—psoriasis	9.62e-05	0.000343	CcSEcCtD
Nisoldipine—Feeling abnormal—Dexamethasone—psoriasis	9.62e-05	0.000343	CcSEcCtD
Nisoldipine—Hypersensitivity—Triamcinolone—psoriasis	9.48e-05	0.000338	CcSEcCtD
Nisoldipine—Rash—Mycophenolate mofetil—psoriasis	9.46e-05	0.000337	CcSEcCtD
Nisoldipine—Dermatitis—Mycophenolate mofetil—psoriasis	9.45e-05	0.000337	CcSEcCtD
Nisoldipine—Headache—Mycophenolate mofetil—psoriasis	9.4e-05	0.000335	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—psoriasis	9.39e-05	0.000335	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—psoriasis	9.36e-05	0.000334	CcSEcCtD
Nisoldipine—Diarrhoea—Hydrocortisone—psoriasis	9.35e-05	0.000334	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—psoriasis	9.32e-05	0.000332	CcSEcCtD
Nisoldipine—Urticaria—Dexamethasone—psoriasis	9.28e-05	0.000331	CcSEcCtD
Nisoldipine—Urticaria—Betamethasone—psoriasis	9.28e-05	0.000331	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Prednisone—psoriasis	9.26e-05	0.00033	CcSEcCtD
Nisoldipine—Dizziness—Prednisolone—psoriasis	9.25e-05	0.00033	CcSEcCtD
Nisoldipine—Body temperature increased—Betamethasone—psoriasis	9.23e-05	0.000329	CcSEcCtD
Nisoldipine—Body temperature increased—Dexamethasone—psoriasis	9.23e-05	0.000329	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—psoriasis	9.2e-05	0.000328	CcSEcCtD
Nisoldipine—Nausea—Cyclosporine—psoriasis	9.13e-05	0.000326	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—psoriasis	9.13e-05	0.000326	CcSEcCtD
Nisoldipine—Pruritus—Triamcinolone—psoriasis	9.11e-05	0.000325	CcSEcCtD
Nisoldipine—Cough—Methotrexate—psoriasis	9.09e-05	0.000324	CcSEcCtD
Nisoldipine—Dizziness—Hydrocortisone—psoriasis	9.04e-05	0.000322	CcSEcCtD
Nisoldipine—Dyspepsia—Prednisone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Nisoldipine—Nausea—Mycophenolate mofetil—psoriasis	8.91e-05	0.000318	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—psoriasis	8.87e-05	0.000316	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—psoriasis	8.87e-05	0.000316	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—psoriasis	8.87e-05	0.000316	CcSEcCtD
Nisoldipine—Decreased appetite—Prednisone—psoriasis	8.84e-05	0.000315	CcSEcCtD
Nisoldipine—Rash—Prednisolone—psoriasis	8.82e-05	0.000315	CcSEcCtD
Nisoldipine—Dermatitis—Prednisolone—psoriasis	8.82e-05	0.000314	CcSEcCtD
Nisoldipine—Headache—Prednisolone—psoriasis	8.77e-05	0.000313	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—psoriasis	8.76e-05	0.000312	CcSEcCtD
Nisoldipine—Rash—Hydrocortisone—psoriasis	8.62e-05	0.000307	CcSEcCtD
Nisoldipine—CYP3A7—Xenobiotics—CYP2S1—psoriasis	8.61e-05	0.0709	CbGpPWpGaD
Nisoldipine—Dermatitis—Hydrocortisone—psoriasis	8.61e-05	0.000307	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—psoriasis	8.57e-05	0.000306	CcSEcCtD
Nisoldipine—Headache—Hydrocortisone—psoriasis	8.56e-05	0.000305	CcSEcCtD
Nisoldipine—Dizziness—Triamcinolone—psoriasis	8.51e-05	0.000304	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisone—psoriasis	8.38e-05	0.000299	CcSEcCtD
Nisoldipine—Nausea—Prednisolone—psoriasis	8.31e-05	0.000296	CcSEcCtD
Nisoldipine—Pruritus—Betamethasone—psoriasis	8.26e-05	0.000295	CcSEcCtD
Nisoldipine—Pruritus—Dexamethasone—psoriasis	8.26e-05	0.000295	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—psoriasis	8.22e-05	0.000293	CcSEcCtD
Nisoldipine—Nausea—Hydrocortisone—psoriasis	8.12e-05	0.00029	CcSEcCtD
Nisoldipine—Rash—Triamcinolone—psoriasis	8.11e-05	0.000289	CcSEcCtD
Nisoldipine—Dermatitis—Triamcinolone—psoriasis	8.11e-05	0.000289	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—psoriasis	8.1e-05	0.000289	CcSEcCtD
Nisoldipine—Urticaria—Prednisone—psoriasis	8.08e-05	0.000288	CcSEcCtD
Nisoldipine—Headache—Triamcinolone—psoriasis	8.06e-05	0.000288	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—psoriasis	8.04e-05	0.000287	CcSEcCtD
Nisoldipine—Diarrhoea—Dexamethasone—psoriasis	7.99e-05	0.000285	CcSEcCtD
Nisoldipine—Diarrhoea—Betamethasone—psoriasis	7.99e-05	0.000285	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—psoriasis	7.94e-05	0.000283	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—psoriasis	7.74e-05	0.000276	CcSEcCtD
Nisoldipine—Dizziness—Betamethasone—psoriasis	7.72e-05	0.000275	CcSEcCtD
Nisoldipine—Dizziness—Dexamethasone—psoriasis	7.72e-05	0.000275	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—psoriasis	7.69e-05	0.000274	CcSEcCtD
Nisoldipine—Nausea—Triamcinolone—psoriasis	7.64e-05	0.000273	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—psoriasis	7.63e-05	0.000272	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—psoriasis	7.58e-05	0.00027	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—psoriasis	7.56e-05	0.000269	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisone—psoriasis	7.49e-05	0.000267	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—psoriasis	7.48e-05	0.000267	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—psoriasis	7.39e-05	0.000264	CcSEcCtD
Nisoldipine—Rash—Dexamethasone—psoriasis	7.36e-05	0.000263	CcSEcCtD
Nisoldipine—Rash—Betamethasone—psoriasis	7.36e-05	0.000263	CcSEcCtD
Nisoldipine—Dermatitis—Dexamethasone—psoriasis	7.36e-05	0.000262	CcSEcCtD
Nisoldipine—Dermatitis—Betamethasone—psoriasis	7.36e-05	0.000262	CcSEcCtD
Nisoldipine—Headache—Betamethasone—psoriasis	7.32e-05	0.000261	CcSEcCtD
Nisoldipine—Headache—Dexamethasone—psoriasis	7.32e-05	0.000261	CcSEcCtD
Nisoldipine—Pruritus—Prednisone—psoriasis	7.19e-05	0.000257	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—psoriasis	7e-05	0.00025	CcSEcCtD
Nisoldipine—Diarrhoea—Prednisone—psoriasis	6.96e-05	0.000248	CcSEcCtD
Nisoldipine—Nausea—Betamethasone—psoriasis	6.94e-05	0.000247	CcSEcCtD
Nisoldipine—Nausea—Dexamethasone—psoriasis	6.94e-05	0.000247	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—psoriasis	6.75e-05	0.000241	CcSEcCtD
Nisoldipine—Dizziness—Prednisone—psoriasis	6.72e-05	0.00024	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—psoriasis	6.72e-05	0.00024	CcSEcCtD
Nisoldipine—Rash—Prednisone—psoriasis	6.41e-05	0.000229	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—psoriasis	6.41e-05	0.000228	CcSEcCtD
Nisoldipine—Headache—Prednisone—psoriasis	6.37e-05	0.000227	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—psoriasis	6.26e-05	0.000223	CcSEcCtD
Nisoldipine—CYP3A5—Xenobiotics—CYP2S1—psoriasis	6.23e-05	0.0513	CbGpPWpGaD
Nisoldipine—Nausea—Prednisone—psoriasis	6.04e-05	0.000215	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—psoriasis	6.01e-05	0.000214	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—psoriasis	5.81e-05	0.000207	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—psoriasis	5.62e-05	0.0002	CcSEcCtD
Nisoldipine—Rash—Methotrexate—psoriasis	5.36e-05	0.000191	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—psoriasis	5.35e-05	0.000191	CcSEcCtD
Nisoldipine—Headache—Methotrexate—psoriasis	5.32e-05	0.00019	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—psoriasis	5.05e-05	0.00018	CcSEcCtD
Nisoldipine—ABCB1—Allograft Rejection—IL22—psoriasis	3.77e-05	0.031	CbGpPWpGaD
Nisoldipine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	3.75e-05	0.0309	CbGpPWpGaD
Nisoldipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	3.58e-05	0.0294	CbGpPWpGaD
Nisoldipine—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	3.53e-05	0.0291	CbGpPWpGaD
Nisoldipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	3.31e-05	0.0273	CbGpPWpGaD
Nisoldipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.9e-05	0.0239	CbGpPWpGaD
Nisoldipine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	2.89e-05	0.0238	CbGpPWpGaD
Nisoldipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	2.69e-05	0.0222	CbGpPWpGaD
Nisoldipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.59e-05	0.0213	CbGpPWpGaD
Nisoldipine—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.55e-05	0.021	CbGpPWpGaD
Nisoldipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	2.36e-05	0.0195	CbGpPWpGaD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.1e-05	0.0173	CbGpPWpGaD
Nisoldipine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	1.56e-05	0.0128	CbGpPWpGaD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.56e-05	0.0128	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—CYP2S1—psoriasis	1.54e-05	0.0127	CbGpPWpGaD
Nisoldipine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.54e-05	0.0127	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—APOE—psoriasis	1.53e-05	0.0126	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	1.52e-05	0.0125	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—psoriasis	1.32e-05	0.0109	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.26e-05	0.0104	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—APOE—psoriasis	1.24e-05	0.0103	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.2e-05	0.0099	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.19e-05	0.00977	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—TYK2—psoriasis	1.13e-05	0.00931	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP2S1—psoriasis	1.11e-05	0.00917	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	1.1e-05	0.00904	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—APOE—psoriasis	1.09e-05	0.00901	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—psoriasis	1.07e-05	0.00882	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.74e-06	0.00802	CbGpPWpGaD
Nisoldipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.61e-06	0.00791	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—psoriasis	9.41e-06	0.00775	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	9.25e-06	0.00762	CbGpPWpGaD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.96e-06	0.00738	CbGpPWpGaD
Nisoldipine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	7.63e-06	0.00628	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	7.47e-06	0.00615	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—CARM1—psoriasis	7.4e-06	0.0061	CbGpPWpGaD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.15e-06	0.00589	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.14e-06	0.00588	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL13—psoriasis	7.1e-06	0.00584	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—TNF—psoriasis	7.09e-06	0.00584	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	6.71e-06	0.00552	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	6.61e-06	0.00545	CbGpPWpGaD
Nisoldipine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	6.6e-06	0.00544	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL17A—psoriasis	6.53e-06	0.00538	CbGpPWpGaD
Nisoldipine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	6.5e-06	0.00535	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	6.45e-06	0.00531	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—CARM1—psoriasis	6.35e-06	0.00523	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—TP53—psoriasis	6.25e-06	0.00515	CbGpPWpGaD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.25e-06	0.00514	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NDUFA5—psoriasis	6.08e-06	0.00501	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL12B—psoriasis	6.07e-06	0.005	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—CARM1—psoriasis	6.01e-06	0.00495	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-E—psoriasis	5.93e-06	0.00488	CbGpPWpGaD
Nisoldipine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	5.79e-06	0.00476	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TNF—psoriasis	5.76e-06	0.00474	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NDUFA5—psoriasis	5.76e-06	0.00474	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—IL6—psoriasis	5.53e-06	0.00456	CbGpPWpGaD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.52e-06	0.00455	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—CARM1—psoriasis	5.28e-06	0.00435	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—psoriasis	5.24e-06	0.00431	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.18e-06	0.00426	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP2S1—psoriasis	5.17e-06	0.00426	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.1e-06	0.0042	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—psoriasis	5.08e-06	0.00418	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TNF—psoriasis	5.06e-06	0.00417	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NDUFA5—psoriasis	5.06e-06	0.00417	CbGpPWpGaD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.99e-06	0.00411	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.91e-06	0.00404	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP2S1—psoriasis	4.9e-06	0.00403	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	4.6e-06	0.00379	CbGpPWpGaD
Nisoldipine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.47e-06	0.00368	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—psoriasis	4.46e-06	0.00367	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL10—psoriasis	4.44e-06	0.00366	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL4—psoriasis	4.32e-06	0.00356	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP2S1—psoriasis	4.3e-06	0.00354	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.22e-06	0.00348	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.22e-06	0.00347	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.93e-06	0.00324	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.91e-06	0.00322	CbGpPWpGaD
Nisoldipine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.87e-06	0.00318	CbGpPWpGaD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.85e-06	0.00317	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—TYK2—psoriasis	3.78e-06	0.00312	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.58e-06	0.00294	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—LEP—psoriasis	3.54e-06	0.00291	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—TYK2—psoriasis	3.24e-06	0.00267	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.21e-06	0.00265	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NDUFA5—psoriasis	3.1e-06	0.00255	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—PPARG—psoriasis	3.08e-06	0.00254	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—TYK2—psoriasis	3.07e-06	0.00253	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—LEP—psoriasis	3.03e-06	0.0025	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—LEP—psoriasis	2.87e-06	0.00237	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.78e-06	0.00229	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TYK2—psoriasis	2.7e-06	0.00222	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—TYK2—psoriasis	2.7e-06	0.00222	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—VEGFA—psoriasis	2.68e-06	0.0022	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.67e-06	0.0022	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—PPARG—psoriasis	2.64e-06	0.00218	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP2S1—psoriasis	2.63e-06	0.00217	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IFNG—psoriasis	2.61e-06	0.00215	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.61e-06	0.00215	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CARM1—psoriasis	2.52e-06	0.00208	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—LEP—psoriasis	2.52e-06	0.00208	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—PPARG—psoriasis	2.5e-06	0.00206	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.43e-06	0.002	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.43e-06	0.002	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CARM1—psoriasis	2.39e-06	0.00197	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TYK2—psoriasis	2.32e-06	0.00191	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—VEGFA—psoriasis	2.29e-06	0.00189	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.28e-06	0.00187	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NDUFA5—psoriasis	2.24e-06	0.00184	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—PPARG—psoriasis	2.2e-06	0.00181	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TYK2—psoriasis	2.19e-06	0.00181	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—VEGFA—psoriasis	2.17e-06	0.00179	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—NFKB1—psoriasis	2.1e-06	0.00173	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CARM1—psoriasis	2.1e-06	0.00173	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.08e-06	0.00171	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.08e-06	0.00171	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2e-06	0.00165	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.97e-06	0.00162	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TYK2—psoriasis	1.93e-06	0.00159	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—VEGFA—psoriasis	1.91e-06	0.00157	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—VEGFA—psoriasis	1.91e-06	0.00157	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP2S1—psoriasis	1.9e-06	0.00157	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—STAT3—psoriasis	1.89e-06	0.00156	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—IL6—psoriasis	1.85e-06	0.00152	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—NFKB1—psoriasis	1.8e-06	0.00149	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NFKB1—psoriasis	1.71e-06	0.00141	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TNF—psoriasis	1.69e-06	0.00139	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NDUFA5—psoriasis	1.69e-06	0.00139	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.68e-06	0.00138	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—VEGFA—psoriasis	1.64e-06	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TNF—psoriasis	1.64e-06	0.00135	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—STAT3—psoriasis	1.62e-06	0.00133	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—IL6—psoriasis	1.59e-06	0.00131	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.57e-06	0.00129	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CAT—psoriasis	1.55e-06	0.00128	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—VEGFA—psoriasis	1.55e-06	0.00128	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—STAT3—psoriasis	1.54e-06	0.00126	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—IL6—psoriasis	1.5e-06	0.00124	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NFKB1—psoriasis	1.5e-06	0.00124	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.5e-06	0.00123	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CAT—psoriasis	1.47e-06	0.00121	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP2S1—psoriasis	1.44e-06	0.00118	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TNF—psoriasis	1.4e-06	0.00116	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—VEGFA—psoriasis	1.36e-06	0.00112	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—STAT3—psoriasis	1.35e-06	0.00111	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.35e-06	0.00111	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TNF—psoriasis	1.33e-06	0.00109	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—IL6—psoriasis	1.32e-06	0.00109	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—IL6—psoriasis	1.32e-06	0.00109	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CAT—psoriasis	1.29e-06	0.00106	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CARM1—psoriasis	1.29e-06	0.00106	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.26e-06	0.00104	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—APOE—psoriasis	1.21e-06	0.000993	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TNF—psoriasis	1.17e-06	0.000961	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.15e-06	0.000944	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—APOE—psoriasis	1.14e-06	0.000941	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—IL6—psoriasis	1.13e-06	0.000932	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.11e-06	0.000917	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—IL6—psoriasis	1.07e-06	0.000883	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.07e-06	0.000883	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PPARG—psoriasis	1.05e-06	0.000865	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.04e-06	0.000857	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—APOE—psoriasis	1e-06	0.000827	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PPARG—psoriasis	9.95e-07	0.000819	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.73e-07	0.000801	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—IL6—psoriasis	9.42e-07	0.000776	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CARM1—psoriasis	9.3e-07	0.000766	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP2S1—psoriasis	8.85e-07	0.000729	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PPARG—psoriasis	8.74e-07	0.00072	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.34e-07	0.000687	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CAT—psoriasis	7.91e-07	0.000651	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.35e-07	0.000605	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CARM1—psoriasis	7.02e-07	0.000578	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—APOE—psoriasis	6.15e-07	0.000506	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.01e-07	0.000495	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CAT—psoriasis	5.72e-07	0.000471	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CARM1—psoriasis	5.6e-07	0.000461	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PPARG—psoriasis	5.35e-07	0.000441	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.24e-07	0.000431	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—APOE—psoriasis	4.44e-07	0.000366	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CARM1—psoriasis	4.32e-07	0.000356	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CAT—psoriasis	4.32e-07	0.000355	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PPARG—psoriasis	3.87e-07	0.000319	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CAT—psoriasis	3.44e-07	0.000284	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—APOE—psoriasis	3.35e-07	0.000276	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PPARG—psoriasis	2.92e-07	0.00024	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—APOE—psoriasis	2.68e-07	0.00022	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CAT—psoriasis	2.66e-07	0.000219	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PPARG—psoriasis	2.33e-07	0.000192	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—APOE—psoriasis	2.07e-07	0.00017	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PPARG—psoriasis	1.8e-07	0.000148	CbGpPWpGaD
